Session » 3S082: SLE – Clinical II: Flares & Morbidity of SLE (1824–1829)
- 2:30PM-4:00PM
-
Abstract Number: 1829
Ability of Inflammatory and Regulatory Soluble Mediators to Forecast Impending Clinical Disease Flare and Inform a Refined Lupus Flare Prediction Index in a Confirmatory Cohort of SLE Patients
- 2:30PM-4:00PM
-
Abstract Number: 1828
Avascular Necrosis Is Associated with APOL1 Variants in African Americans with Systemic Lupus Erythematosus
- 2:30PM-4:00PM
-
Abstract Number: 1827
Clinical Implications of Neutrophil Extracellular Traps in Systemic Lupus Erythematosus
- 2:30PM-4:00PM
-
Abstract Number: 1825
Comparison of the Thrombosis Risk Score with Triple Positivity in SLE Thrombosis
- 2:30PM-4:00PM
-
Abstract Number: 1826
Describing Intra-Individual Cognitive Function Course over Time in Lupus Patients: Persistent and Fluctuating Cognitive Impairment, Affected Cognitive Domains, and Severity
- 2:30PM-4:00PM
-
Abstract Number: 1824
Perceived Stress Independently Associates with Worse Type 2 Symptoms in Systemic Lupus Erythematosus